Dr. Mohamed O. Othman, MD
Claim this profileBaylor College of Medicine
Studies Gastrointestinal Cancer
Studies Digestive Cancer
17 reported clinical trials
27 drugs studied
Affiliated Hospitals
Clinical Trials Mohamed O. Othman, MD is currently running
DMR
for Type 2 Diabetes
The Revita® system is being investigated to assess the efficacy of DMR versus Sham on improvement in Glycemic, Hepatic and Cardiovascular endpoints for patients with Type 2 Diabetes who are inadequately controlled on one or more glucose lowering agents. The purpose of this study is to demonstrate the efficacy and safety of the Fractyl DMR Procedure using the Revita® System compared to a sham. Subjects randomized to the DMR procedure will be followed per protocol till 48 weeks post treatment. Subjects in the Sham treatment arm will be offered cross over to receive the DMR treatment at 48 weeks and will be followed per protocol for 48 weeks post treatment.
Recruiting0 awards N/A7 criteria
Traction Device
for Digestive System Tumors
The goal of this prospective, randomized, controlled trial conducted at Baylor St. Luke's Medical Center is to compare the effectiveness and clinical outcomes of using a traction device in colonic endoscopic submucosal dissection (ESD) to those of using conventional ESD. The investigators of this study hypothesize that use of the traction device will help expedite colonic endoscopic submucosal dissections.
Recruiting1 award N/A3 criteria
More about Mohamed O. Othman, MD
Clinical Trial Related3 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Mohamed O. Othman, MD has experience with
- Endoscopic Submucosal Dissection
- Traction Device
- Novel Rigidizing Overtube
- Non-hybrid ESD
- Hybrid ESD
- OverStitch Sx
Breakdown of trials Mohamed O. Othman, MD has run
Gastrointestinal Cancer
Digestive Cancer
Gastrointestinal Tumors
Gastrointestinal Neoplasms
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mohamed O. Othman, MD specialize in?
Mohamed O. Othman, MD focuses on Gastrointestinal Cancer and Digestive Cancer. In particular, much of their work with Gastrointestinal Cancer has involved treating patients, or patients who are undergoing treatment.
Is Mohamed O. Othman, MD currently recruiting for clinical trials?
Yes, Mohamed O. Othman, MD is currently recruiting for 3 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Mohamed O. Othman, MD has studied deeply?
Yes, Mohamed O. Othman, MD has studied treatments such as Endoscopic Submucosal Dissection, Traction Device, Novel Rigidizing Overtube.
What is the best way to schedule an appointment with Mohamed O. Othman, MD?
Apply for one of the trials that Mohamed O. Othman, MD is conducting.
What is the office address of Mohamed O. Othman, MD?
The office of Mohamed O. Othman, MD is located at: Baylor College of Medicine, Houston, Texas 77030 United States. This is the address for their practice at the Baylor College of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.